Trade setup intelligence
Charts, patterns, liquidity, and profile weighting stay together before a setup is surfaced.
Signal through the silt.
Stocks, crypto and news catalysts, ranked into decisions
Follow market prices, charts and current catalysts without an account. When you need a decision workflow, move into ranked intelligence with data-quality checks and risk-aware review.
- Public markets
- Stocks · Crypto · NFTs
- Catalysts
- Source attributed
- Member intelligence
- Risk gated
Automated Market Intelligence
News Catalysts Mixed Directly with Stock Signals
News aggregation engine
Market-moving headlines are normalized, scored, and matched to the stocks they can move.
Automated controls
Automation is gated by data quality, risk limits, and explicit confidence thresholds.
Signal Workflow
Built Around the Decision Path
Ingest
Market headlines and bars enter one data-quality boundary.
Score
Catalysts are separated into bullish, neutral, and bearish context.
Rank
Opportunity boards blend catalyst impact with chart and risk signals.
Control
Execution-facing actions stay behind operator and risk checks.
Current Catalysts
Latest Market Headlines
Source-attributed headlines captured in the last hours, each linked to the public stock and crypto pages it mentions. Browse all market news
Novavax, Nvidia, MercadoLibre, Nu Holdings and PTC: Why These 5 Stocks Are on Investors' Radars Today
NVAX, NVDA, MELI, NU, PTC were among the stocks seen trending on Monday, Oct. 5, 2026.
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Nike Stock Near 52-Week Lows: Can Its Dividend and Caitlin Clark Spark a Rebound?
Nike's Q1 results showed mixed performance with revenue declining 4% year-over-year and weak guidance for fiscal 2027, pushing stock near 52-week lows. While the company's 5% dividend yield is attractive and Caitlin Clark's signature shoe launch shows promise for women's sports growth, significant risks remain including declining sales, Greater China challenges, and weak direct-to-consumer performance. Zacks rates NKE as a Strong Sell.
Advanced Micro Devices vs. Intel: Which Semiconductor Stock Is a Better Buy in 2026?
AMD and Intel are competing for dominance in the AI chip market. AMD is experiencing rapid growth with 34.3% revenue increase and strong data center performance, while Intel is undergoing a turnaround with improving results but negative free cash flow. The article recommends AMD as the better buy due to faster growth, cleaner business trajectory, and lower execution risk.
Want Income for Life? Coca-Cola Has Raised Its Dividend for 64 Straight Years and Yields 2.5%. Here's Whether It Belongs in Your Portfolio.
Coca-Cola is a Dividend King with 64 consecutive years of dividend increases and a 2.5% yield, but the article argues the stock looks expensive at 26x earnings and underperforms the S&P 500 over 10 and 20-year periods. With Treasury yields at 5.3%, investors may find better returns elsewhere, and the author recommends waiting for a pullback before adding shares.
Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock
Eli Lilly, the only healthcare stock in the trillion-dollar club, has rallied 400% over five years driven by its successful GLP-1 drugs Mounjaro and Zepbound. However, with a valuation of 40x trailing earnings and slowing growth prospects, the stock faces significant headwinds from intensifying competition in the GLP-1 market from companies like Pfizer and Viking Therapeutics. The author suggests the stock may have more downside risk than upside potential at current valuations.
Real signals or no signal
The system only ranks opportunities when real market and catalyst data is available. Missing data produces a clear unavailable state instead of noise.
Review integrations